Related Experiment Video
Updated: Apr 30, 2026
05:18
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
232
[Left ventricle assist device: rehabilitation and management programmes].
M-C D'agrosa-Boiteux1, E Geoffroy2, N Dauphin2
1Clinique de cardiopneumologie, 8, avenue de la Paix, 63830 Durtol, France.
Annales De Cardiologie Et D'Angeiologie
|April 29, 2014
Summary
Medical management of systolic dysfunction heart failure improves survival. Advanced heart failure cases are increasing, but left ventricular assist devices offer new hope and rehabilitation strategies.
Area of Science:
- Cardiology
- Medical Technology
- Rehabilitation Medicine
Background:
- Medical management of heart failure with systolic dysfunction has improved patient survival and quality of life.
- Therapeutic advancements have led to a changing clinical profile and an increase in advanced heart failure cases.
- Technological progress in left ventricular assist devices (LVADs) presents significant hope for patients with advanced heart failure.
Purpose of the Study:
- To present our experience in managing patients with advanced heart failure.
- To describe the rehabilitation program implemented for these patients.
- To highlight the role of left ventricular assist devices in improving outcomes.
Main Methods:
- Review of patient management strategies for advanced heart failure.
- Description of a comprehensive rehabilitation program.
- Analysis of outcomes associated with left ventricular assist device therapy.
Main Results:
- Improved survival rates and quality of life in patients with heart failure with systolic dysfunction.
- Increased prevalence of advanced heart failure cases requiring innovative solutions.
- Positive impact of left ventricular assist devices and rehabilitation on patient recovery.
Conclusions:
- Left ventricular assist devices offer a viable and hopeful option for patients with advanced heart failure.
- Integrated management and rehabilitation programs are crucial for optimizing patient outcomes.
- Continued advancements in medical and technological interventions are vital for managing the evolving landscape of heart failure.
Keywords:
Assistance circulatoireCardiac rehabilitationHeart failureHeart transplantationInsuffisance cardiaque avancéeLeft ventricular assist deviceRéadaptation cardiaqueTransplantation cardiaqueMore Related Videos
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
01:22Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
01:30Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:26Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
01:25Mitral Regurgitation III: Medical Management
686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686